USPTO serial 79188687
OPIS
Reviewed by CopyMark Law Group
Reg. 5488596Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 12, 2018
- Examiner
- TANNER, MICHAEL R
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with OPIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw Hogan Lovells US LLP555 13th Street NWWashington, DC 20004UNITED STATES OF AMERICAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting in the fields of clinical research and health research; Regulatory submission management for the pharmaceutical and biotechnology industries, namely, assisting others in preparing and filing applications for clinical trial approval, pharmaceutical and health product approval | ACTIVE | — |
| 042 | Research and development in the medical, pharmaceutical and biotechnological fields, namely, Pharmaceutical research and development, Research and development in the pharmaceutical and biotechnology fields; [ Pharmaceutical products development; ] Conducting and monitoring clinical trials for pharmaceutical products, namely, conducting clinical trials for others, monitoring pharmaceutical clinical trials for others for quality control purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a searchable database in the fields of medical, pharmaceutical and biotechnological research; Database development services for others to process data collected from clinical trials; Pharmacovigilance, namely, monitoring pharmaceutical clinical trials for others for quality control purposes, conducting quality evaluation and analysis, quality assurance, and quality control testing for others in the pharmaceutical field; Toxicology services; Contract research organization services for pharmaceutical development and clinical development and trial, namely, conducting clinical trials for others; designing and developing software for others for use in managing data in the medical, pharmaceutical and biotechnological industries | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Feb 24, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Sep 10, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 2, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 2, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jan 2, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jan 2, 2025 | PRAN | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | — |
| Dec 30, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 4, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 12, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 13, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 13, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 13, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 13, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 9, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 9, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 9, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 9, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 9, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 6, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 19, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 18, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 12, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 12, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 7, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 18, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 13, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 5, 2017 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Sep 5, 2017 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Sep 5, 2017 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Aug 17, 2017 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 17, 2017 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Aug 17, 2017 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Apr 27, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 22, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 22, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 22, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 29, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 13, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 12, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |